Abstract Search

ea0014oc3.5 | Endocrine tumors & neoplasia | ECE2007

[¹²³I]Iodometomidate as a radiotracer for adrenal scintigraphy – first clinical experience

Hahner Stefanie , Stuermer Andrea , Fassnacht Martin , Kreissl Michael , Reiners Christoph , Beuschlein Felix , Zink Martina , Zolle Ilse , Schirbel Andreas , Allolio Bruno

Adrenal masses are highly prevalent tumours comprising of a variety of entities. Therefore, therapeutic consequences also vary considerably. The CYP11B-specific PET-tracer [11C]metomidate has been shown to be suitable to characterize adrenal lesions. However, its availability is restricted to PET-centers with an on-site cyclotron. Also imaging is hindered by the short tracer half-life (20 min). Therefore, we have developed [123I]iodometomidate as a tracer...

0 shares

Endocrine Abstracts

[¹²³I]Iodometomidate as a radiotracer for adrenal scintigraphy – first clinical experience

BiosciAbstracts

Endocrine Abstracts

[123I]Iodometomidate as a radiotracer for adrenal scintigraphy – first clinical experience

BiosciAbstracts

[¹²³I]Iodometomidate as a radiotracer for adrenal scintigraphy – first clinical experience